These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 32869326)

  • 1. Prevalence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus in United States blood donations, 2015 to 2019: The Transfusion-Transmissible Infections Monitoring System (TTIMS).
    Steele WR; Dodd RY; Notari EP; Xu M; Nelson D; Kessler DA; Reik R; Williams AE; Custer B; Stramer SL;
    Transfusion; 2020 Oct; 60(10):2327-2339. PubMed ID: 32869326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV, HCV, and HBV incidence and residual risk in US blood donors before and after implementation of the 12-month deferral policy for men who have sex with men.
    Steele WR; Dodd RY; Notari EP; Haynes J; Anderson SA; Williams AE; Reik R; Kessler D; Custer B; Stramer SL;
    Transfusion; 2021 Mar; 61(3):839-850. PubMed ID: 33460470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in prevalence, incidence, and residual risk of major transfusion-transmissible viral infections in United Arab Emirates blood donors: impact of individual-donation nucleic acid testing, 2004 through 2009.
    Al Shaer L; AbdulRahman M; John TJ; AlHashimi A
    Transfusion; 2012 Nov; 52(11):2300-9. PubMed ID: 22691239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends and epidemiological analysis of hepatitis B virus, hepatitis C virus, human immunodeficiency virus, and human T-cell lymphotropic virus among Iranian blood donors: strategies for improving blood safety.
    Omidkhoda A; Razi B; Arabkhazaeli A; Amini Kafi-Abad S
    BMC Infect Dis; 2020 Oct; 20(1):736. PubMed ID: 33028232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predonation screening of candidate donors and prevention of window period donations.
    Lieshout-Krikke RW; Zaaijer HL; van de Laar TJ
    Transfusion; 2015 Feb; 55(2):373-8. PubMed ID: 25130605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and trends of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among blood donors in Iran, 2004 through 2007.
    Kafi-abad SA; Rezvan H; Abolghasemi H; Talebian A
    Transfusion; 2009 Oct; 49(10):2214-20. PubMed ID: 19527477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.
    Velati C; Romanò L; Fomiatti L; Baruffi L; Zanetti AR;
    Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of hepatitis B virus, hepatitis C virus, human immunodeficiency virus and Treponema pallidum infections in hospitalized patients before transfusion in Xiangya hospital Central South University, China from 2011 to 2016.
    Cao WW; Zhou RR; Ou X; Shi LX; Xiao CQ; Chen TY; Tan H; Fan XG; Li BJ; Li N
    BMC Infect Dis; 2018 Apr; 18(1):145. PubMed ID: 29606088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of nucleic acid testing to detect human immunodeficiency virus, hepatitis C virus, and hepatitis B virus yields from a single blood center in China with 10-years review.
    Wu D; Feng F; Wang X; Wang D; Hu Y; Yu Y; Huang J; Wang M; Dong J; Wu Y; Zhu H; Zhu F
    BMC Infect Dis; 2022 Mar; 22(1):279. PubMed ID: 35321684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in incidence and prevalence of major transfusion-transmissible viral infections in US blood donors, 1991 to 1996. Retrovirus Epidemiology Donor Study (REDS).
    Glynn SA; Kleinman SH; Schreiber GB; Busch MP; Wright DJ; Smith JW; Nass CC; Williams AE
    JAMA; 2000 Jul; 284(2):229-35. PubMed ID: 10889598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of the risk of hepatitis B virus, hepatitis C virus and human immunodeficiency virus infectious donations entering the blood supply in England, 1993-2001.
    Soldan K; Barbara JA; Ramsay ME; Hall AJ
    Vox Sang; 2003 May; 84(4):274-86. PubMed ID: 12757501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroprevalence of infectious markers & their trends in blood donors in a hospital based blood bank in north India.
    Makroo RN; Hegde V; Chowdhry M; Bhatia A; Rosamma NL
    Indian J Med Res; 2015 Sep; 142(3):317-22. PubMed ID: 26458348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B, Hepatitis C and human immunodeficiency virus prevalences among first time blood donors in Istanbul, Turkey, 2004-2011.
    Tigen ET; Doğru A; Karadağ FY
    Transfus Apher Sci; 2015 Oct; 53(2):176-9. PubMed ID: 25881737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and Trends of Transfusion-Transmissible Viral Infections among Blood Donors in South of Iran: An Eleven-Year Retrospective Study.
    Farshadpour F; Taherkhani R; Tajbakhsh S; Gholizadeh Tangestani M; Hajiani G; Sharifi N; Taherkhani S; Nejadbolkheyr A
    PLoS One; 2016; 11(6):e0157615. PubMed ID: 27309959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of triplex nucleic acid test assays in United States blood donors.
    Stramer SL; Krysztof DE; Brodsky JP; Fickett TA; Reynolds B; Dodd RY; Kleinman SH
    Transfusion; 2013 Oct; 53(10 Pt 2):2525-37. PubMed ID: 23550838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
    Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R
    Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitivity and specificity of a new automated system for the detection of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus nucleic acid in blood and plasma donations.
    Galel SA; Simon TL; Williamson PC; AuBuchon JP; Waxman DA; Erickson Y; Bertuzis R; Duncan JR; Malhotra K; Vaks J; Huynh N; Pate LL
    Transfusion; 2018 Mar; 58(3):649-659. PubMed ID: 29250788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroprevalence and diagnosis of HIV, HBV, HCV and syphilis infections among blood donors.
    Tafesse TB; Gebru AA; Gobalee S; Belay GD; Belew MT; Ataro D; Ebrahim BA; Shebeshi GM; Yimam Y
    Hum Antibodies; 2017; 25(1-2):39-55. PubMed ID: 28009328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transfusion-transmissible infections among blood donors in Kathmandu, Nepal.
    Shrestha AC; Ghimire P; Tiwari BR; Rajkarnikar M
    J Infect Dev Ctries; 2009 Dec; 3(10):794-7. PubMed ID: 20009282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood donors' positivity for transfusion-transmissible infections: the Serbian Military Medical Academy experience.
    Vučetić D; Kecman G; Ilić V; Balint B
    Blood Transfus; 2015 Oct; 13(4):569-75. PubMed ID: 26057495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.